Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible

Cyril X. George1, Charles E. Samuel2,1
1Department of Molecular, Cellular, and Developmental Biology, and Interdepartmental Program of Biochemistry and Molecular Biology, University of California, Santa Barbara, CA 93106
2Department of Molecular, Cellular and Developmental Biology and

Tóm tắt

RNA-specific adenosine deaminase (ADAR1) catalyzes the deamination of adenosine to inosine in viral and cellular RNAs. Two size forms of the ADAR1 editing enzyme are known, an IFN-inducible ≈150-kDa protein and a constitutively expressed N-terminally truncated ≈110-kDa protein. We have now identified alternative exon 1 structures of human ADAR1 transcripts that initiate from unique promoters, one constitutively expressed and the other IFN inducible. Cloning and sequence analyses of 5′-rapid amplification of cDNA ends (RACE) cDNAs from human placenta established a linkage between exon 2 of ADAR1 and two alternative exon 1 structures, designated herein as exon 1A and exon 1B. Analysis of RNA isolated from untreated and IFN-treated human amnion cells demonstrated that exon 1B–exon 2 transcripts were synthesized in the absence of IFN and were not significantly altered in amount by IFN treatment. By contrast, exon 1A–exon 2 transcripts were IFN inducible. Transient transfection analysis with reporter constructs led to the identification of two functional promoters, designated P C and P I . Exon 1B transcripts were initiated from the P C promoter whose activity in transient transfection reporter assays was not increased by IFN treatment. The 107-nt exon 1B mapped 14.5 kb upstream of exon 2. The 201-nt exon 1A that mapped 5.4 kb upstream of exon 2 was initiated from the interferon-inducible P I promoter. These results suggest that two promoters, one IFN inducible and the other not, initiate transcription of the ADAR1 gene, and that alternative splicing of unique exon 1 structures to a common exon 2 junction generates RNA transcripts with the deduced coding capacity for either the constitutively expressed ≈110-kDa ADAR1 protein (exon 1B) or the interferon-induced ≈150-kDa ADAR1 protein (exon 1A).

Từ khóa


Tài liệu tham khảo

L Simpson, R B Emeson Annu Rev Neurosci 19, 27–52 (1996).

S M Rueter, R B Emeson Modifications and Editing of RNA (Am. Soc. Microbiol., Washington, D.C.), pp. 343–361 (1998).

P H Seeburg, M Higuchi, R Sprengel Brain Res Rev 26, 217–229 (1998).

B L Bass Trends Biochem Sci 22, 157–162 (1997).

C M Burns, H Chu, S M Rueter, L K Hutchinson, H Canton, E Sanders-Bush, R B Emeson Nature (London) 387, 303–308 (1997).

R Cattaneo Curr Opin Genet Dev 4, 895–900 (1994).

M Kumar, G G Carmichael Proc Natl Acad Sci USA 94, 3542–3547 (1997).

B L Bass, K Nishikura, W Keller, P H Seeburg, R B Emeson, M A O’Connell, C E Samuel, A Herbert RNA 3, 947–949 (1997).

J B Patterson, C E Samuel Mol Cell Biol 15, 5376–5388 (1995).

U Kim, Y Wang, T Sanford, Y Zeng, K Nishikura Proc Natl Acad Sci USA 91, 11457–11461 (1994).

M A O’Connell, S Krause, M Higuchi, J J Hsuan, N F Totty, A Jenny, W Keller Mol Cell Biol 15, 1389–1397 (1995).

A Herbert, J Alfken, Y-G Kim, I S Mian, K Nishikura, A Rich Proc Natl Acad Sci USA 94, 8421–8426 (1997).

J B Patterson, D C Thomis, S L Hans, C E Samuel Virology 210, 508–511 (1995).

Y Liu, C X George, J B Patterson, C E Samuel J Biol Chem 272, 4419–4428 (1997).

H-U G Weier, C X George, K M Greulich, C E Samuel Genomics 30, 372–375 (1995).

C X George, C E Samuel Gene 229, 203–213 (1999).

M G Wathelet, J Szpirer, C B Nols, I M Clauss, L De Wit, M Q Islam, G Levan, M A Horisberger, J Content, C Szpirer, et al. Somatic Cell Mol Genet 14, 415–426 (1988).

Y Liu, C E Samuel J Biol Chem 274, 5070–5077 (1999).

S D Der, A Zhou, B R G Williams, R H Silverman Proc Natl Acad Sci USA 95, 15623–15628 (1998).

R W Wagner, C Yoo, L Wrabetz, J Kamholz, J Buchhalter, N F Hassan, K Khalili, S U Kim, B Perussia, F A McMorris, et al. Mol Cell Biol 10, 5586–5590 (1990).

A D J Scadden, C W J Smith EMBO J 16, 2140–2149 (1997).

N S Shepherd, B D Pfrogner, J N Coulby, S L Ackerman, G Vaidyanathan, R H Sauer, T C Balkenhol, N Sternberg Proc Natl Acad Sci USA 91, 2629–2633 (1994).

J Sambrook, E F Fritsch, T Maniatis Molecular Cloning, a Laboratory Manual. (Cold Spring Harbor Lab. Press, 2nd Ed., Plainview, NY, 1989).

H Tanaka, C E Samuel Proc Natl Acad Sci USA 91, 7995–7999 (1994).

E M Southern J Mol Biol 98, 503–517 (1975).

F Sanger, S Nicklen, A R Coulson Proc Natl Acad Sci USA 74, 5463–5467 (1977).

M A Frohman, M Dush, G R Martin Proc Natl Acad Sci USA 85, 8998–9002 (1988).

D C Thomis, G Floyd-Smith, C E Samuel J Biol Chem 267, 10723–10728 (1992).

R K Saiki, S Scharf, F Faloona, K B Mullis, G T Horn, H A Erlich, N Arnheim Science 230, 1350–1354 (1985).

K L Kuhen, C E Samuel Virology 227, 119–130 (1997).

K L Kuhen, J W Vessey, C E Samuel J Virol 72, 9934–9939 (1998).

Y Wang, Y Zeng, J M Murray, K Nishikura J Mol Biol 254, 184–195 (1995).

Y Liu, A Herbert, A Rich, C E Samuel Methods Companion Methods Enzymol 15, 199–205 (1998).

R Javahery, A Khachi, K Lo, B Zenzie-Gregory, S T Smale Mol Cell Biol 14, 116–127 (1994).

S Faisst, S Meyer Nucleic Acids Res 20, 3–26 (1992).

M Kozak J Cell Biol 108, 229–241 (1989).

H Lodish, D Baltimore, A Berk, S L Zipursky, P Matsudaira, J Darnell Molecular Cell Biology (Freeman, 3rd Ed., New York, 1995).

O Okladnova, Y V Syagailo, R Mossner, P Riederer, I-P Lesch Mol Brain Res 60, 177–192 (1998).

G Chalepakis, A Stoykova, J Wijnholds, P Tremblay, P Gruss J Neurobiol 24, 1367–1384 (1993).

M Nakamuta, K Oka, J Krushkal, K Kobayashi, M Yamamoto, W-H Li, L Chan J Biol Chem 270, 13042–13056 (1995).